1189 related articles for article (PubMed ID: 24933225)
1. Triptolide: progress on research in pharmacodynamics and toxicology.
Li XJ; Jiang ZZ; Zhang LY
J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
[TBL] [Abstract][Full Text] [Related]
2. [Advanced progress of main pharmacology activities of triptolide].
Cui J; Chen X; Su JC
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2655-2658. PubMed ID: 29098818
[TBL] [Abstract][Full Text] [Related]
3. [Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders].
Pan XD; Chen XC
Yao Xue Xue Bao; 2008 Dec; 43(12):1179-85. PubMed ID: 19244746
[TBL] [Abstract][Full Text] [Related]
4. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide.
Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J
J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.
Qiu D; Kao PN
Drugs R D; 2003; 4(1):1-18. PubMed ID: 12568630
[TBL] [Abstract][Full Text] [Related]
6. [Progress in research on mechanisms of anti-rheumatoid arthritis of triptolide].
Liu CF; Lin N
Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(19):1575-9. PubMed ID: 17165577
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii.
Ma J; Dey M; Yang H; Poulev A; Pouleva R; Dorn R; Lipsky PE; Kennelly EJ; Raskin I
Phytochemistry; 2007 Apr; 68(8):1172-8. PubMed ID: 17399748
[TBL] [Abstract][Full Text] [Related]
8. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.
Zhou ZL; Yang YX; Ding J; Li YC; Miao ZH
Nat Prod Rep; 2012 Apr; 29(4):457-75. PubMed ID: 22270059
[TBL] [Abstract][Full Text] [Related]
9. Triptolide and its expanding multiple pharmacological functions.
Liu Q
Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694
[TBL] [Abstract][Full Text] [Related]
10. [Progress in research on triptolide].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):170-4. PubMed ID: 15719629
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Neurodegenerative Diseases with Bioactive Components of
Li J; Hao J
Am J Chin Med; 2019; 47(4):769-785. PubMed ID: 31091976
[No Abstract] [Full Text] [Related]
12. Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis.
Shen Q; Wang J; Yuan Z; Jiang Z; Shu T; Xu D; He J; Zhang L; Huang X
Int Immunopharmacol; 2019 Dec; 77():105959. PubMed ID: 31644961
[TBL] [Abstract][Full Text] [Related]
13. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide.
Zhang Q; Li Y; Liu M; Duan J; Zhou X; Zhu H
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351251
[No Abstract] [Full Text] [Related]
14. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription.
Wang B; Ma L; Tao X; Lipsky PE
Arthritis Rheum; 2004 Sep; 50(9):2995-303. PubMed ID: 15457469
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of triptolide and the molecular mechanisms involved.
Xi C; Peng S; Wu Z; Zhou Q; Zhou J
Biomed Pharmacother; 2017 Jun; 90():531-541. PubMed ID: 28402922
[TBL] [Abstract][Full Text] [Related]
16. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats.
Tai T; Huang X; Su Y; Ji J; Su Y; Jiang Z; Zhang L
J Ethnopharmacol; 2014 Mar; 152(2):358-63. PubMed ID: 24486211
[TBL] [Abstract][Full Text] [Related]
18. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats.
Wang SR; Chen X; Ling S; Ni RZ; Guo H; Xu JW
Biomed Pharmacother; 2019 Mar; 111():1467-1477. PubMed ID: 30841462
[TBL] [Abstract][Full Text] [Related]
20. Triptolide: reflections on two decades of research and prospects for the future.
Tong L; Zhao Q; Datan E; Lin GQ; Minn I; Pomper MG; Yu B; Romo D; He QL; Liu JO
Nat Prod Rep; 2021 Apr; 38(4):843-860. PubMed ID: 33146205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
